| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |